283 related articles for article (PubMed ID: 23783552)
81. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
[TBL] [Abstract][Full Text] [Related]
82. Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116.
Wang Z; Chen H
Anticancer Res; 2010 Nov; 30(11):4537-45. PubMed ID: 21115903
[TBL] [Abstract][Full Text] [Related]
83. Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma.
Yang X; Hu F; Liu JA; Yu S; Cheung MPL; Liu X; Ng IO; Guan XY; Wong KKW; Sharma R; Lung HL; Jiao Y; Lee LTO; Cheung M
Oncogene; 2020 May; 39(20):4061-4076. PubMed ID: 32214200
[TBL] [Abstract][Full Text] [Related]
84. CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth.
Kim TY; Jackson S; Xiong Y; Whitsett TG; Lobello JR; Weiss GJ; Tran NL; Bang YJ; Der CJ
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16868-73. PubMed ID: 24082123
[TBL] [Abstract][Full Text] [Related]
85. CKIP-1 acts as a colonic tumor suppressor by repressing oncogenic Smurf1 synthesis and promoting Smurf1 autodegradation.
Nie J; Liu L; Xing G; Zhang M; Wei R; Guo M; Li X; Xie P; Li L; He F; Han W; Zhang L
Oncogene; 2014 Jul; 33(28):3677-87. PubMed ID: 23995790
[TBL] [Abstract][Full Text] [Related]
86. Epigenetic silencing of glutaminase 2 in human liver and colon cancers.
Zhang J; Wang C; Chen M; Cao J; Zhong Y; Chen L; Shen HM; Xia D
BMC Cancer; 2013 Dec; 13():601. PubMed ID: 24330717
[TBL] [Abstract][Full Text] [Related]
87. Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma.
Bryan JN; Jabbes M; Berent LM; Arthur GL; Taylor KH; Rissetto KC; Henry CJ; Rahmatpanah F; Rankin WV; Villamil JA; Lewis MR; Caldwell CW
BMC Genet; 2009 Nov; 10():73. PubMed ID: 19912643
[TBL] [Abstract][Full Text] [Related]
88. Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications.
O'Connell MR; Sarkar S; Luthra GK; Okugawa Y; Toiyama Y; Gajjar AH; Qiu S; Goel A; Singh P
Sci Rep; 2015 Oct; 5():14983. PubMed ID: 26447334
[TBL] [Abstract][Full Text] [Related]
89. Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel.
Shen L; Kondo Y; Ahmed S; Boumber Y; Konishi K; Guo Y; Chen X; Vilaythong JN; Issa JP
Cancer Res; 2007 Dec; 67(23):11335-43. PubMed ID: 18056460
[TBL] [Abstract][Full Text] [Related]
90. A tumor suppressor DLC1: The functions and signal pathways.
Zhang Y; Li G
J Cell Physiol; 2020 Jun; 235(6):4999-5007. PubMed ID: 31773748
[TBL] [Abstract][Full Text] [Related]
91. Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells.
Du X; Qian X; Papageorge A; Schetter AJ; Vass WC; Liu X; Braverman R; Robles AI; Lowy DR
Cancer Res; 2012 Sep; 72(17):4405-16. PubMed ID: 22693251
[TBL] [Abstract][Full Text] [Related]
92. Hypermethylation of NDN promotes cell proliferation by activating the Wnt signaling pathway in colorectal cancer.
Hu YH; Chen Q; Lu YX; Zhang JM; Lin C; Zhang F; Zhang WJ; Li XM; Zhang W; Li XN
Oncotarget; 2017 Jul; 8(28):46191-46203. PubMed ID: 28521288
[TBL] [Abstract][Full Text] [Related]
93. Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma.
Pan J; Li D; Fan X; Cheng J; Jin S; Chen P; Lin H; Li Y
DNA Cell Biol; 2023 Mar; 42(3):140-150. PubMed ID: 36917700
[TBL] [Abstract][Full Text] [Related]
94. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.
Neri F; Dettori D; Incarnato D; Krepelova A; Rapelli S; Maldotti M; Parlato C; Paliogiannis P; Oliviero S
Oncogene; 2015 Aug; 34(32):4168-76. PubMed ID: 25362856
[TBL] [Abstract][Full Text] [Related]
95. Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer.
Chang G; Xu S; Dhir R; Chandran U; O'Keefe DS; Greenberg NM; Gingrich JR
Clin Cancer Res; 2010 Nov; 16(22):5390-401. PubMed ID: 21062931
[TBL] [Abstract][Full Text] [Related]
96. Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration.
Heering J; Erlmann P; Olayioye MA
Exp Cell Res; 2009 Sep; 315(15):2505-14. PubMed ID: 19482022
[TBL] [Abstract][Full Text] [Related]
97. Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.
Yang WT; Zheng PS
PLoS One; 2014; 9(2):e88827. PubMed ID: 24551169
[TBL] [Abstract][Full Text] [Related]
98. CD81 is a candidate tumor suppressor gene in human gastric cancer.
Yoo TH; Ryu BK; Lee MG; Chi SG
Cell Oncol (Dordr); 2013 Apr; 36(2):141-53. PubMed ID: 23264205
[TBL] [Abstract][Full Text] [Related]
99. The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity.
Basak P; Dillon R; Leslie H; Raouf A; Mowat MR
BMC Cancer; 2015 Sep; 15():630. PubMed ID: 26353792
[TBL] [Abstract][Full Text] [Related]
100. Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding.
Victoria-Acosta G; Vazquez-Santillan K; Jimenez-Hernandez L; Muñoz-Galindo L; Maldonado V; Martinez-Ruiz GU; Melendez-Zajgla J
Sci Rep; 2015 Oct; 5():14838. PubMed ID: 26443201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
